Overview

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this pilot study is to obtain a preliminary assessment of the antiviral activity and tolerability of Kaletra single agent therapy as initial treatment for HIV infection, relative to a Kaletra three drug standard of care reference arm

Phase:

Phase 3

Details

Lead Sponsor:

Abbott

Treatments:

Lamivudine
Lamivudine, zidovudine drug combination
Lopinavir
Ritonavir
Zidovudine